Pharmaceuticals (Basel, Switzerland)

PloS one

Physical chemistry chemical physics : PCCP

Dalton transactions (Cambridge, England : 2003)

Proceedings of the National Academy of Sciences of the United States of America

Theranostics

Data in brief

PLoS computational biology

Environmental research

Journal of controlled release : official journal of the Controlled Release Society

oncotarget

Chemical science

Cancers

clinical proteomics

european journal of surgical oncology : the journal of the european society of surgical oncology and the british association of surgical oncology

journal of food and drug analysis

International journal of surgery (London, England)

Frontiers in oncology

journal of cellular physiology

Journal of applied clinical medical physics

health promotion journal of australia : official journal of australian association of health promotion professionals

Clinical orthopaedics and related research

Aging

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

bmc gastroenterology

Histochemistry and cell biology

bjs open

pancreatology : official journal of the international association of pancreatology (iap) [et al]

[1] Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect).

[2] What Are the Implications of Alternative Alpha Thresholds for Hypothesis Testing in Orthopaedics?

[3] Crystal chemistry and physical properties of the AM(HO)[BPO(OH)] (A = Cs, Rb; M = Ni, Cu, (Ni, Fe)) borophosphate family.

[4] Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis.

[5] Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.

[6] Application of cancer screening test for the detection of pancreatic tumor in genetically engineered mice.

[7] Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancreatic cancer.

[8] The Use of (Network) Meta-Analysis in Clinical Oncology.

[9] Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.

[10] Effects of self- and partner's online disclosure on relationship intimacy and satisfaction.

[11] Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.

[12] Needle tract seeding recurrence of pancreatic cancer in the gastric wall with paragastric lymph node metastasis after endoscopic ultrasound-guided fine needle aspiration followed by pancreatectomy: a case report and literature review.

[13] International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer.

[14] Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes.

[15] Governing for Health: Advancing Health and Equity through Policy and Advocacy.

[16] Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.

[17] Tricellular tight junction protein LSR/angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line.

[18] Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses.

[19] Unravelling the mechanism of cobalt-catalysed remote C-H nitration of 8-aminoquinolinamides and expansion of substrate scope towards 1-naphthylpicolinamide.

[20] On the microscopic origin of the cryoprotective effect in lysine solutions.

[21] Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma

[22] pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis

[23] in vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice

[24] definition of microscopic tumor clearance (r0) in pancreatic cancer resections

[25] postoperative hepatic arterial infusion chemotherapy improved survival of pancreatic cancer after radical pancreatectomy: a retrospective study

[26] synchronous primary renal cell carcinoma and pancreatic ductal adenocarcinoma: case report and literature review

[27] identification of two kinase inhibitors with synergistic toxicity with low-dose hydrogen peroxide in colorectal cancer cells in vitro

[28] convenient preparation of 18f-labeled peptide probes for potential claudin-4 pet imaging

[29] selection and outcome of portal vein resection in pancreatic cancer

[30] signal-targeted therapies and resistance mechanisms in pancreatic cancer: future developments reside in proteomics

[31] Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma.

[32] a near-complete response to treatment with gemcitabine plus nab®-paclitaxel in a patient with metastatic pancreatic cancer and poor performance status: a case report

[33] role of pancreatic stellate cells in chemoresistance in pancreatic cancer

[34] pancreatic cancer

[35] vascular targeting in pancreatic cancer: the novel tubulin-binding agent zd6126 reveals antitumor activity in primary and metastatic tumor models

[36] 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth

[37] intercalated duct cell is starting point in development of pancreatic ductal carcinoma?

[38] curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production

[39] oxaliplatin-induced hyperammonemic encephalopathy in a patient with metastatic pancreatic cancer: a case report

[40] cell volume regulation in epithelial physiology and cancer

[41] a quad-element uwb-mimo antenna with band-notch and reduced mutual coupling based on ebg structures

[42] the potential for circulating tumor cells in pancreatic cancer management

[43] body-mass index and pancreatic cancer incidence: a pooled analysis of nine population-based cohort studies with more than 340,000 japanese subjects

[44] a phase ii study of pelareorep (reolysin®) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma

[45] Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy.

[46] [Magnetic resonance tomography in diagnosis of vascular infiltration in malignant pancreas tumors].

[47] 2288 Validation of the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram after surgery for localized pancreatic adenocarcinoma: Long-term results from a Spanish pancreatic cancer surgery reference centre

[48] Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer

[49] Predictors of Financial Toxicity Trajectories in Patients With Pancreatic Cancer: A Latent Class Growth Analysis.

[50] Emerging biomarkers for pancreatic cancer: from early detection to personalized therapy.

[51] Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC‐1)

[52] Synthesis of gold nanoparticles from leaf Panax notoginseng and its anticancer activity in pancreatic cancer PANC-1 cell lines

[53] Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief

[54] Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy.

[55] A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy.

[56] Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study.

[57] Author's Reply to: “Design flaws in statins and pancreatic cancer research” (IJC-19-0941)

[58] The impact of a new hepatopancreatobiliary surgery program on the management of pancreatic cancer at Health Sciences North

[59] Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.

[60] Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer.

[61] Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer.

[62] Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

[63] Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect).

[64] Health behaviours and beliefs in individuals with familial pancreatic cancer.

[65] A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene.

[66] Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.

[67] Portal-Mesenteric Vein Resection in Borderline Pancreatic Cancer; 33 Month-Survival in Patients with Good Performance Status.

[68] Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement

[69] Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study.

[70] Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.

[71] Is Screening for Pancreatic Cancer in High-Risk Individuals One Step Closer or a Fool's Errand?

[72] Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer Stroma.

[73] Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancreatic cancer.

[74] Time to Adjuvant Systemic Therapy Following Pancreatic Cancer Resection and Effect on Outcome.

[75] Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles

[76] Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy.

[77] Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms

[78] Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis

[79] Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells.

[80] Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.

[81] Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.

[82] Pancreatic cancer: a neglected killer?

[83] Financial Impact of Complex Cancer Surgery in India: A Study of Pancreatic Cancer

[84] Needle tract seeding recurrence of pancreatic cancer in the gastric wall with paragastric lymph node metastasis after endoscopic ultrasound-guided fine needle aspiration followed by pancreatectomy: a case report and literature review.

[85] International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer.

[86] miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis

[87] Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes.

[88] Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.

[89] Mechanistic multi-scale pharmacokinetic model for the anticancer drug gemcitabine in pancreatic cancer.

[90] Tricellular tight junction protein LSR/angulin-1 contributes to the epithelial barrier and malignancy in human pancreatic cancer cell line.

[91] Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer

[92] Pancreatic cancer vaccine: a unique potential therapy

[93] Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.

[94] The Evolutionary Origins of Recurrent Pancreatic Cancer.

[95] Soy food intake and pancreatic cancer risk: The Japan Public Health Center-based Prospective Study.

[96] Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4).

[97] Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer

[98] A percutaneous biopsy technique for patients with suspected biliary or pancreatic cancer without a radiographic mass

[99] An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model

[100] ultra sensitivity silicon-based photonic crystal microcavity biosensors for plasma protein detection in patients with pancreatic cancer

[101] definition of microscopic tumor clearance (r0) in pancreatic cancer resections